Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Pais

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Circulation|June 15, 2014
Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control studyDarryl P Leong, Andrew Smyth, Koon K Teo, et al.
Cardiovascular Diabetology|March 10, 2023
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trialEdward Franek, Prem Pais, Jan Basile, et al.
Lancet (London, England)|September 15, 2004
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studySalim Yusuf, Steven Hawken, Stephanie Ounpuu, et al.
Kidney International|November 7, 2022
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney diseaseJohannes F E Mann, Philip Joseph, Peggy Gao, et al.
JAMA|January 18, 2007
Risk factors for early myocardial infarction in South Asians compared with individuals in other countriesPrashant Joshi, Shofiqul Islam, Prem Pais, et al.
American Heart Journal|January 6, 2005
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarctionSalim Yusuf, Shamir R Mehta, Rafael Díaz, et al.
Journal of the American College of Cardiology|March 17, 2018
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of DiabetesBrendan M Everett, Marc Y Donath, Aruna D Pradhan, et al.
Plos One|January 27, 2021
A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failureDeepak Y Kamath, K B Bhuvana, Luke Joshua Salazar, et al.
American Heart Journal|March 10, 2010
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatmentJohn W Eikelboom, Martin O'Donnell, Salim Yusuf, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Circulation|June 15, 2014
Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control studyDarryl P Leong, Andrew Smyth, Koon K Teo, et al.
Cardiovascular Diabetology|March 10, 2023
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trialEdward Franek, Prem Pais, Jan Basile, et al.
Lancet (London, England)|September 15, 2004
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studySalim Yusuf, Steven Hawken, Stephanie Ounpuu, et al.
Kidney International|November 7, 2022
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney diseaseJohannes F E Mann, Philip Joseph, Peggy Gao, et al.
JAMA|January 18, 2007
Risk factors for early myocardial infarction in South Asians compared with individuals in other countriesPrashant Joshi, Shofiqul Islam, Prem Pais, et al.
American Heart Journal|January 6, 2005
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarctionSalim Yusuf, Shamir R Mehta, Rafael Díaz, et al.
Journal of the American College of Cardiology|March 17, 2018
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of DiabetesBrendan M Everett, Marc Y Donath, Aruna D Pradhan, et al.
Plos One|January 27, 2021
A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failureDeepak Y Kamath, K B Bhuvana, Luke Joshua Salazar, et al.
American Heart Journal|March 10, 2010
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatmentJohn W Eikelboom, Martin O'Donnell, Salim Yusuf, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
Pageof 11